SCHEMBL7130323

SCHEMBL7130323

O=C(Nc1nc(-c2cccc3ccccc23)cs1)c1cc([N+](=O)[O-])ccc1Cl

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RORC P51449 6/20 0.63
▸ MEN1 O00255 11/20 0.59
▸ KMT2A Q03164 11/20 0.59
▸ MAPT P10636 7/20 0.59
▸ ALDH1A1 P00352 4/20 0.59
▸ KDM4E B2RXH2 2/20 0.59
▸ SMN1; SMN2 Q16637 3/20 0.54
▸ HTT P42858 3/20 0.54
▸ CYP1A2 P05177 2/20 0.53
▸ CYP3A4 P08684 2/20 0.53
▸ CYP2C9 P11712 2/20 0.53
▸ CYP2C19 P33261 2/20 0.53
▸ LMNA P02545 2/20 0.53
▸ TP53 P04637 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ PPARG P37231 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127473 0.87 RORC (0.61) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL7128794 0.85 MEN1 (0.69) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL27571286 0.85 RORC (0.53) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL7130345 0.84 MEN1 (0.73) MEN1KMT2AMAPTALDH1A1KDM4E
SCHEMBL19435568 0.83 RAB9A (0.61) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL7128929 0.83 RAB9A (0.67) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL27571288 0.82 ADORA3 (0.71) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL27589570 0.81 HSP90AA1 (0.59) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL7127621 0.81 ABL1 (0.63) RORCMEN1KMT2AMAPTALDH1A1
SCHEMBL7125926 0.81 MEN1 (0.64) RORCMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 — — CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 — — US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD RORC 67/4885MEN1 4865/4885KMT2A 3291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback